Question:

A patient with iron deficiency anemia has thrombocytosis on blood counts. What is the most appropriate next step in management?

Show Hint

Common causes of reactive thrombocytosis include Iron deficiency, Infection, Inflammation (like Rheumatoid Arthritis or IBD), Surgery, Trauma, and Splenectomy (or functional asplenia).
Unlike essential thrombocythemia, reactive thrombocytosis rarely causes thrombotic or hemorrhagic complications.
Updated On: Sep 3, 2026
  • Treat IDA and repeat platelets
  • Start hydroxyurea
  • Bone marrow biopsy
  • Test for JAK2 mutation
Show Solution
collegedunia
Verified By Collegedunia

The Correct Option is A

Solution and Explanation

Concept:
A patient presents with a dual finding on a complete blood count: Iron Deficiency Anemia (IDA) and an elevated platelet count (thrombocytosis).
The question asks for the most appropriate immediate clinical action in this common scenario.
Explanation:
• Thrombocytosis (platelet count typically $>$ 450,000/$\mu$L) can be broadly categorized into primary (clonal/essential) and secondary (reactive) etiologies.

• Reactive thrombocytosis is extremely common and accounts for the vast majority of cases in clinical practice.

• One of the most frequent causes of reactive thrombocytosis is Iron Deficiency Anemia (IDA).

• The exact mechanism is not entirely elucidated, but it is hypothesized that elevated levels of erythropoietin (produced in response to anemia) possess structural homology with thrombopoietin (TPO).

• Consequently, high erythropoietin can cross-react with and stimulate TPO receptors on megakaryocytes, driving increased platelet production.

• Additionally, iron acts as an inhibitor of megakaryopoiesis; thus, a lack of iron removes this inhibition, further increasing platelet counts.

• Because the thrombocytosis is secondary to the iron deficiency, it is benign and will resolve once the underlying iron deficiency is corrected.

• Therefore, the most appropriate and conservative first step is to prescribe iron supplementation to treat the IDA and subsequently monitor the blood counts.

• If the platelet count normalizes as the anemia resolves, the diagnosis of reactive thrombocytosis is confirmed.

• Testing for a JAK2 mutation (Option D) or performing a bone marrow biopsy (Option C) would only be indicated if the thrombocytosis persists after the iron stores are repleted, raising suspicion for a primary myeloproliferative neoplasm such as Essential Thrombocythemia (ET).

• Starting cytoreductive therapy like hydroxyurea (Option B) is inappropriate and potentially dangerous for reactive thrombocytosis.
Final answer:
The correct approach is to treat the underlying cause (IDA) and observe for the normalization of platelet counts.
Was this answer helpful?
0
0

Top NEET SS Medical Questions

View More Questions

Top NEET SS Questions

View More Questions